PressPostoperative pain: the power of morphine without the side effects
Opiorphin, and a stabilized form of opiorphin known as STR-324, are just as effective as morphine for the treatment of postoperative pain. But these two molecules do not have the same worrying side effects as morphine, such as cardiorespiratory problems. This discovery was made in animals; the first trials in humans should begin at the end of 2017. These findings by scientists from Gustave Roussy, ...
Agenda2017 New Year ceremony
The Institut Pasteur's senior management team will give its New Year message to all staff on Friday January 6, 2017, at 10.00am. Christian Bréchot will take this opportunity to speak about the challenges, breakthroughs and successes that have marked the year 2016. We will also hear from Christian Vigouroux, the newly elected Chairman of the Institut Pasteur's Board of Directors. We hope that ...
Art and scienceCome and discover a "Pasteurian" artwork at the Centre Pompidou
Organoid. This strange term might make you think of "a new structure resembling an organ" - or you might have already heard it being used to refer to an interdisciplinary project between artists and Institut Pasteur scientists. "Organoid", launched in 2014 by the artist Fabrice Hyber and the Institut Pasteur – represented by Olivier Schwartz acting as scientific coordinator ...
SEASON'S GREETINGS2017 New Year cards
The digital version of the 2017 New Year's card is now available to share via email and social media. A traditional paper format of this card will be available on Monday at the Enzymes Shop in the François Jacob Building. Read on for important details about sharing the card both formats. Using the 2017 Digital Card To send your New Year's greetings by email follow these steps: PC: If ...
NewsletterLast issue before January 6, 2017
The Institut Pasteur newsletter team wishes you a Merry Christmas and a Happy New Year!
FundingNews - December 16, 2016
Appel à Projets de recherche sur la mucoviscidose 2017 - Vaincre la Mucoviscidose (VLM) Objet: soutenir la recherche sur la mucoviscidose. Domaines concernés : recherche fondamentale, recherche translationnelle, recherche clinique et recherche en sciences humaines et sociales Eligibilité: - les demandes de financements ne peuvent être portées que par un personnel statutaire (salarié en CDI, du ...